Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blood
; 139(8): 1198-1207, 2022 02 24.
Article
in En
| MEDLINE
| ID: mdl-34469514
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasms, Second Primary
/
Bridged Bicyclo Compounds, Heterocyclic
/
Hematologic Neoplasms
/
Myelopoiesis
/
Bcl-2-Associated X Protein
/
Mutation
/
Myeloproliferative Disorders
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2022
Type:
Article
Affiliation country:
Australia